Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $8.3500 (-5.01%) ($8.2600 - $8.9200) on Tue. Mar. 5, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.61% (three month average) | RSI | 36 | Latest Price | $8.3500(-5.01%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.2% a day on average for past five trading days. | Weekly Trend | BCRX declines -2.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XLC(5%) IBB(3%) TBT(3%) BLOK(2%) VXX(2%) | Factors Impacting BCRX price | BCRX will decline at least -1.805% in a week (0% probabilities). SLV(-12%) SIL(-9%) GLD(-8%) GDXJ(-8%) GDX(-8%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.805% (StdDev 3.61%) | Hourly BBV | 0 () | Intraday Trend | -4.9% | | | |
|
1 - 5 Day Possible Target | $2.18(-73.89%) | Resistance Level | $8.81 | 5 Day Moving Average | $8.48(-1.53%) | 10 Day Moving Average | $8.6(-2.91%) | 20 Day Moving Average | $8.81(-5.22%) | To recent high | -14.1% | To recent low | 18.3% | Market Cap | $1.473b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |